Table 2.
Surgical results
| SSA group (n = 61) | Control group (n = 62) | P | |
|---|---|---|---|
| Operative approach (n, %) | 0.928 | ||
| LG | 30 (49.2) | 31 (50.0) | |
| RG | 31 (50.8) | 31 (50.0) | |
| Extent of resection (n, %) | 1.000 | ||
| Proximal | 5 (8.2) | 4 (6.5) | |
| Distal | 39 (63.9) | 40 (64.5) | |
| Total | 17 (27.9) | 18 (29.0) | |
| Reconstruction (n, %) | 1.000 | ||
| Double-tract | 4 (6.6) | 4 (6.5) | |
| Billroth II | 40 (65.6) | 40 (64.5) | |
| Roux-en-Y | 17 (27.9) | 18 (29.0) | |
| Tumor size, cm, (mean ± SD) | 2.2 ± 1.1 | 2.3 ± 1.1 | 0.509 |
| Surgical time, min, (mean ± SD) | 235.6 ± 41.3 | 232.2 ± 42.0 | 0.652 |
| Blood loss, mL, (mean ± SD) | 47.9 ± 34.3 | 50.1 ± 35.5 | 0.726 |
| Number of lymph nodes, (mean ± SD) | 26.7 ± 10.7 | 29.0 ± 9.7 | 0.223 |
SSA somatostatin analog, LG laparoscopic gastrectomy, RG robotic gastrectomy, SD standard deviation